Loading...

VNRX VOLITIONRX LTD Management Changes 8-K Filing

VLTN

VNRX

VOLITIONRX LTD

(VNRX)

2024 8-K

Show Summary

Summary

Financial Results Announcement

Equity Offerings

Increase in authorized shares

Financial Statements

Share Sale Agreement

Stock Registration

Financial Results

Management Appointment

Director Appointment

Management Changes

Oncology Portfolio

Financial Results

Annual Meeting Approval and...

Earnings Reports

Financial Results and Busin...

Financing Round

Amendment to Stock Incentiv...

Agreement for Public Offering

External Links:

VolitionRx Ltd appointed Timothy Still as a non-executive Chairman and Director, effective November 6, 2024, with a compensation package including $30,000 quarterly and 1.4 million RSUs based on performance and stock price targets.

AI Assistant

VOLITIONRX LTD

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.